000538:SHE
Yunnan Baiyao Group Co Ltd
CNÂ¥50.44
arrow_upward
+0.40%(+0.20) 1D
Sep 30, 3:04:03 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000538...
Open
CNÂ¥50.25
High
CNÂ¥50.55
Low
CNÂ¥49.97
Mkt. cap
90.00B
Avg. vol.
7.28M
Volume
0.00
Dividend
5.20%
Quarterly dividend
CNÂ¥0.66
Ex-dividend date
Apr 30, 2026
P/E ratio
17.24
52-wk high
CNÂ¥58.20
52-wk low
CNÂ¥46.29
EPS
CNÂ¥2.93
Shares outstanding
1.78B
No. of employees
9K
Open
CNÂ¥50.25
High
CNÂ¥50.55
Low
CNÂ¥49.97
Mkt. cap
90.00B
Avg. vol.
7.28M
Volume
0.00
Dividend
5.20%
Quarterly dividend
CNÂ¥0.66
Ex-dividend date
Apr 30, 2026
P/E ratio
17.24
52-wk high
CNÂ¥58.20
52-wk low
CNÂ¥46.29
EPS
CNÂ¥2.93
Shares outstanding
1.78B
No. of employees
9K
News stories
From web sources and news partners
AD HOC NEWS
·
4 hours ago
Yunnan Baiyao stock reports CNY 10.28 billion in Q2 revenue
Profile
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products.
The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species".
As of 2024, state and individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
About Yunnan Baiyao Group Co Ltd